The incident took place in Sir Sunderlal Hospital in Varanasi, Uttar Pradesh. Unsplash
MedBound Blog

Varanasi: Patient Has His Surgery Deferred Due to Misbehavior with the Doctor

A hospital decided to take strict action against a patient for misbehavior. A patient's surgery was recently deferred due to misbehavior with a junior resident.

Author : Dr. Amey Patil

Misbehavior with a doctor or any healthcare staff has been a common norm in India. These incidences also culminate into unfortunate events of violence against doctors.

However, a hospital decided to take strict action against a patient for misbehavior. A patient's surgery was recently deferred due to misbehavior with a junior resident.

The incident took place in Sir Sunderlal Hospital in Varanasi, Uttar Pradesh. It is a teaching hospital affiliated with the Institute of Medical Sciences (IMS), Banaras Hindu University, in Varanasi.

The 42-year-old male patient was diagnosed with Varicose veins in his lower limb. Misbehavior with a junior resident has got his surgery deferred. The type of misbehavior isn't clear yet.

Misbehavior with a junior resident has got his surgery deferred. The type of misbehavior isn't clear yet.

One may question the ethical ramifications of this incident. However, the new Medical Ethics Regulations drafted by the National Medical Commission (NMC) in 2022 allow doctors to do so.

The draft states that doctors can now refuse to treat "abusive, unruly, and violent patients or relatives."

(Input from various media sources)

Beed PHC Doctor Faces Action After 11-Year-Old Girl Allegedly Forced Out of Ambulance Over Diesel Money

Maharashtra Orders Hospitals to Display Treatment Charges in Marathi and English: What Patients Need to Know About the New Directive

FDA Issues Early Alert and Recall Notice for Philips Lumify Ultrasound Systems After Four Deaths and Eight Serious Injuries

Pharma Bro Martin Shkreli Faces FTC Contempt Over 60 Pharma Stock Trades Despite Lifetime Ban: Could He Face Jail Time?

2 Dead After Allegedly Consuming Counterfeit Eli Lilly ‘Retatrutide’ Drug Not Approved for Marketing or Commercial Use; FDA Report